Latest Transformation News

Omega Oil and Gas has secured a significant 19.43% equity interest in Elixir Energy, deepening its footprint in Queensland’s Taroom Trough and gaining exposure to near-term drilling catalysts.

Pure Foods Tasmania has acquired premium ice cream brand Elato, integrating it with its Cashew Creamery to form a new Ice Cream Division led by Elato’s founder. This move broadens PFT’s product range and leverages existing manufacturing capabilities.

Aguia Resources has appointed Tim Hosking as its new CEO, signaling a strategic push towards phosphate production in Brazil set for early 2026, while addressing operational challenges at its Colombian gold project.

Trigg Minerals has revealed a significant northern extension of high-grade antimony mineralisation at its Antimony Canyon Project in Utah, confirming bonanza-grade continuity and validating its exploration model.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Kaiser Reef Limited is set to commence a substantial drilling program at its Union Hill waste dumps within the Maldon Gold Project, aiming to unlock significant low-grade gold resources and support ongoing processing operations.

HeraMED has inked a 12-month commercial agreement with Philips’ U.S. subsidiary to deliver an integrated digital maternity care platform to American hospitals, combining cutting-edge monitoring devices with HeraMED’s remote patient monitoring technology.

Barton Gold Holdings has completed its Phase 1 drilling at the Tunkillia Gold Project ahead of schedule and under budget, targeting the high-value S1 and S2 pits. The company anticipates strong cash flow and rapid payback from the S1 pit, with assay results expected soon.

Osteopore Limited has partnered with DKSH Malaysia in a five-year agreement to distribute its innovative dental products, aiming to capture significant growth in Malaysia’s guided bone regeneration sector.

Chrysos Corporation reports nearly one million monthly PhotonAssay samples and reiterates strong FY26 revenue guidance, while unveiling next-gen assay technologies and global expansion plans.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.

Chimeric Therapeutics has received a $4.5 million R&D tax incentive refund from the Australian Government, underscoring its ongoing investment in innovative cancer cell therapies.